TDOC · Teladoc Health, Inc.
$6.50
+0.14 (+2.20%)
At close · Aug 28
View the 10-Q filed Jul 30, 2026
Customer concentration
— key customers 31% of revenue
Key customers — 31% of revenue (six months ended June 30, 2026)
“Revenue from the five largest Clients accounted for 31% of total Integrated Care segment revenue for each of the six months ended June 30, 2026 and 2025.”
Market Cap
$1.18B
Shares
181.68M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.53B
-1.5%
FY2025
Net Income
-$200.32M
+80%
FY2025
Gross Margin
69.2%
-4.4pp
FY2018
Operating Margin
-10.39%
+29.3pp
FY2025
Diluted EPS
-$1.14
+80.6%
FY2025
Operating Cash Flow
$294.36M
+0.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.36B – $2.45B | $2.49B | $2.53BG | $2.57BG | $2.6BG | $2.41BG | $2.03B | $1.09B | $553.31M | $417.91M | $233.28M | $123.16M | $77.38M | $43.53M | $19.91M | |
| — | -$142K | — | — | — | -$9.27M | -$80.37M | -$59.95M | -$29.36M | -$26.11M | -$17.49M | -$2.59M | -$2.2M | -$1.5M | -$56K | |
| — | $755.14M | — | — | — | $743.99M | $650.26M | $390.83M | $184.47M | $128.74M | $61.62M | $31.97M | $21.04M | $9.93M | $4.19M | |
| — | $310.28M | — | — | — | — | — | — | — | $289.17M | $171.66M | $91.19M | $56.34M | $33.6M | $15.72M | |
| — | — | — | — | — | — | — | — | — | 69.2% | 73.58% | 74.04% | 72.81% | 77.19% | 78.97% | |
| — | $269.91M | $277.92M | $307.27M | $348.52M | $333.63M | $311.88M | $164.94M | $64.64M | $54.37M | $34.46M | $21.82M | $14.21M | $7.57M | $3.53M | |
| — | $417.13M | $431.89M | $435.49M | $464.66M | $449.86M | $438.01M | $506.68M | $164.46M | $116.92M | $79.78M | $48.57M | $42.98M | $17.69M | $8.77M | |
| — | $356.06M | $350.76M | $363.37M | $325.93M | $244.62M | $195.3M | $64.7M | $35.6M | $31.5M | $15.3M | $6.1M | $3.7M | $2M | $600K | |
| — | $315.27M | — | — | — | $256.03M | $204.24M | $69.5M | $38.95M | $35.6M | $19.1M | $8.27M | $4.86M | $2.32M | $754K | |
| — | — | $18.79M | $20.36M | $16.94M | $7.42M | — | — | — | $1.21M | — | — | — | — | — | |
| — | $2.68B | $2.79B | $3.59B | $2.85B | $16.06B | $2.3B | $1.6B | $633.75M | $488.76M | $308.67M | — | — | — | — | |
| — | -$186.82M | -$262.96M | -$1.02B | -$248.55M | -$13.65B | -$265.63M | -$506.42M | -$80.44M | -$70.85M | -$75.39M | -$62.66M | -$55.79M | -$15.15M | -$5.87M | |
| — | — | -10.39% | -39.73% | -9.55% | -567.27% | -13.07% | -46.29% | -14.54% | -16.95% | -32.32% | -50.88% | -72.09% | -34.81% | -29.48% | |
| — | -$3.71B | — | — | — | -$13.4B | -$61.39M | -$436.93M | -$41.49M | -$35.25M | -$56.3M | -$54.39M | -$50.92M | -$12.83M | -$5.12M | |
| — | $19.95M | $19.71M | $23.8M | $22.28M | $21.94M | $81.14M | — | — | — | — | — | — | — | — | |
| — | $27M | $36.77M | $57.07M | $46.78M | $12.67M | $776K | — | — | — | — | — | — | — | — | |
| — | -$2.82M | $10.37M | -$6.04M | $4.45M | -$859K | $5.09M | -$545K | $342K | — | — | — | — | — | — | |
| — | -$182.59M | -$235.53M | -$993.65M | -$219.61M | -$13.66B | -$384.66M | -$575.99M | -$109.46M | -$96.97M | -$107.01M | -$73.71M | -$57.98M | -$16.65M | -$5.93M | |
| — | -$5.2M | -$35.21M | $7.59M | $760K | -$3.81M | $44.14M | -$90.86M | -$10.59M | $118K | -$225K | $510K | $36K | $388K | $94K | |
| — | -$177.4M | -$200.32M | -$1B | -$220.37M | -$13.66B | -$428.79M | -$485.14M | -$98.86M | -$97.08M | -$106.78M | -$74.22M | -$58.02M | -$17.04M | -$6.02M | |
| — | — | -7.92% | -38.97% | -8.47% | -567.53% | -21.09% | -44.35% | -17.87% | -23.23% | -45.77% | -60.26% | -74.98% | -39.14% | -30.24% | |
| — | — | — | — | — | — | — | — | — | — | — | -$74.22M | -$58.02M | -$20.13M | -$9.84M | |
| — | -$175.93M | -$196.66M | -$1B | -$214.58M | -$13.7B | -$453.6M | -$449.38M | -$103.03M | -$114.24M | -$102.69M | -$74.18M | -$58.06M | -$17.04M | -$6.02M | |
| USD/shares | — | -$0.99 | -$1.14 | -$5.87 | -$1.34 | -$84.60 | -$2.73 | -$5.36 | -$1.38 | — | — | — | — | — | — |
| USD/shares | — | -$0.99 | -$1.14G | -$5.87 | -$1.34 | -$84.60 | -$2.73 | -$5.36 | -$1.38 | — | — | — | — | — | — |
| shares | — | — | 176.22M | 170.56M | 164.58M | 161.46M | 156.94M | 90.51M | 71.84M | 65.84M | 55.43M | 42.33M | 19.92M | 1.96M | 1.22M |
| shares | — | — | 176.22M | 170.56M | 164.58M | 161.46M | 156.94M | 90.51M | 71.84M | 65.84M | 55.43M | 42.33M | 19.92M | 1.96M | 1.22M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2013–FY2014: $439K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 3.28×
EV/EBIT
—
Peer median 29.79×
P/E (TTM)
—
Peer median 38.63×
Peer medians compare against the 27 similar-size Health Information Services companies (of 45 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Teladoc Health Integrated Care | $1,579,610,000 | $1,528,870,000 | $1,468,794,000 | $1,373,900,000 | $1,300,878,000 | $744,309,000 |
| BetterHelp | $950,367,000 | $1,040,704,000 | $1,133,621,000 | $1,019,646,000 | $721,238,000 | $345,105,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $2,071,739,000 | $2,159,959,000 | $2,237,533,000 | $2,101,015,000 | $1,774,024,000 | $913,720,000 | $423,300,000 | $342,700,000 |
| Non Us | $458,238,000 | $409,615,000 | $364,882,000 | $305,825,000 | $258,683,000 | $180,242,000 | $130,000,000 | $75,200,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Access Fees Revenue | $2,091,941,000 | $2,215,220,000 | $2,282,521,000 | $2,103,814,000 | — | — | — | — |
| Other | $438,036,000 | $354,354,000 | $319,894,000 | $303,026,000 | — | — | — | — |
| Other Revenue | — | — | — | — | $292,537,000 | $246,707,000 | — | $0 |
| Subscription Access Fees | — | — | — | — | $1,740,170,000 | $847,255,000 | $454,206,000 | $350,784,000 |
| Visit Fee Revenue | — | — | — | — | — | — | $99,101,000 | $67,123,000 |
Key facts
CIK
1477449
CUSIP
87918A105
13F (30d)
284 filings
272 filers
Visit website
Investor relations